Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
Music Therapy in Acute Leukemia Patients With Fatigue
- Status
- COMPLETED
- Phase
- NA
Phase I Study of HC-7366 for Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
- Status
- RECRUITING
- Phase
- N/A
The Maintenance Treatment of "ITIVA" in AML Patients
- Status
- RECRUITING
- Phase
- NA
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Study of IBR733 Cell Injection in Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
- Status
- RECRUITING
- Phase
- NA
Cladribine Venetoclax in Monocytic AML
- Status
- RECRUITING
- Phase
- PHASE2
Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- N/A
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
- Status
- RECRUITING
- Phase
- PHASE2
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
- Status
- RECRUITING
- Phase
- PHASE2
A Study of TQB3454 Tablets in Patients With Blood Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1